Key facts
- This page summarizes Christoph Lengauer's Form 4 filing for HOOKIPA Pharma Inc. (HOOK).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 04 Jun 2021, 20:35.
Christoph Lengauer - 01 Jun 2021 Form 4 Insider Report for HOOKIPA Pharma Inc. (HOOK)
- Reporting relationship
- Director
- Issuer ticker
- HOOK
- Reported as of
- 01 Jun 2021
- Net transaction value
- $0
- Reporting owner signature
- /s/ Reinhard Kandera, as Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
3 source fields
Reporting owner
1 detail
Key filing fact
Christoph Lengauer filed Form 4 for HOOKIPA Pharma Inc. (HOOK) on 04 Jun 2021.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
HOOK
transaction
Derivative
Stock Option (Right to Buy)
Award
- Transaction value
- $0
- Shares
- +9,600
- Change %
- Price
- $0.000000
- Shares after
- 9,600
- Date
- 01 Jun 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 9,600
- Exercise price
- $16.61
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
This option shall vest and become fully exercisable on June 1, 2022.